Literature DB >> 9670282

Specification of radiation quality in fast neutron therapy: microdosimetric and radiobiological approach.

J Gueulette1, H G Menzel, P Pihet, A Wambersie.   

Abstract

Specification of radiation quality is an important issue in fast neutron therapy since the biological effectiveness of the beams varies to a large extent with neutron energy. It must meet specific criteria, mainly derived from the accuracy requirement for absorbed dose delivery. A first approach to this problem consists in identifying physical parameters that can be related to Relative Biological Effectiveness (RBE) and which describe the beam production technique (e.g. neutron-producing reaction, p + Be or d + Be, energy of the incident particle). A second is based on microdosimetry, which provides a description of the secondary radiation components to which the biological consequences of irradiations are more directly correlated. A third approach consists in experimental RBE determinations in reference conditions: intestinal crypt regeneration in mice after irradiation to the whole body with single doses is proposed as a standard biological system for radiobiological calibrations of clinical fast neutron beams. Dosimetric, microdosimetric and radiobiological intercomparisons are encouraged since they provide a homogeneous set of data which facilitate the exchange of clinical information. They also constitute a basis for the clinical RBE approach and an overall check of the irradiation procedure. Therefore they should be recommended in every non-conventional radiation therapy facility.

Entities:  

Mesh:

Year:  1998        PMID: 9670282     DOI: 10.1007/978-3-642-78774-4_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  1 in total

1.  Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?

Authors:  T Auberger; B Thürriegl; T Freude; L Weissfloch; R Senekowitsch-Schmidke; P Kneschaurek; F M Wagner; M Molls
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.